Clinical trial
Open-label Extension Study Of RN624
NCT00399490 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00399490 |
|---|---|
| Title | Open-label Extension Study Of RN624 |
| Official title | OPEN-LABEL, MULTIPLE-DOSE STUDY OF THE SAFETY AND EFFICACY OF RN624 IN ADULTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis, OA Knee Pain, Arthritis |
| Intervention type | Drug |
| Interventions | RN624 (PF-04383119) |
| Enrollment | 287 |
| Start date | Sep 15, 2006 |
| Primary completion | Feb 11, 2008 |
| Completion | Feb 11, 2008 |
| First posted | Nov 15, 2006 |
| Last update posted | Feb 2, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: